Abstract:Osteosarcoma (OS) is the most frequent malignant primary bone tumor in children and young adults. Zinc finger Asp-His-His-Cys palmitoyl-acyltransferase 19 (ZDHHC19) is a key enzyme in protein palmitoylation and plays crucial roles in tumor progression. However, its expression profile and biological function in OS have been unclear. In the present study, the expression level of ZDHHC19 in OS cell lines was determined by qRT-PCR and Western blot. The effect of ZDHHC19 in cell growth, invasion and migration was analyzed by CCK8, EDU, transwell, wound healing assay in vitro, and xenograft tumor model in vivo. In addition, bioinformatics analysis was used to explore the potential mechanism of ZDHHC19 in OS. Furthermore, the luciferase reporter assay was conducted to determine the direct binding between miR-940 and ZDHHC19. We discovered that ZDHHC19 was overexpressed in OS cells compared with the normal cells. The functional investigation demonstrated that ZDHHC19 silencing could inhibit proliferation, invasion and migration of OS in vitro and suppress tumorigenicity and lung metastasis in a xenograft model in vivo. Mechanistically, we identified that ZDHHC19 was a direct target of miR-940 and forced ZDHHC19 expressions partially rescue the suppression of proliferation, migration and invasion induced by miR-940. Moreover, bioinformatics analysis combined with validation experiments revealed that activating wnt/β-catenin pathway contributed to the pro-oncogenic effect induced by ZDHHC19. Furthermore, rescue experiments further verified that miR-940/ZDHHC19 axis regulated wnt/β-catenin pathway. Overall, these findings indicated that miR-940/ZDHHC19 axis played a significant role in OS progression and might be considered as a novel target for OS treatment.Abbreviations: OS, osteosarcoma; miRNAs, microRNAs; 3'-UTR, 3'- untranslated region; TARGET, Therapeutically Applicable Research To Generate Effective Treatments; qRT-PCR, quantitative real-time PCR; IHC, Immunohistochemistry; GSVA, Gene Set Variation Analysis; GSEA, Gene Set Enrichment Analysis; KEGG, Kyoto Encyclopedia of Genes and Genomes.

Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression

Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/β-catenin pathway and is upregulated by miR-940 in osteosarcoma

Long non-coding RNA TUG1 regulates the progression and metastasis of osteosarcoma cells via miR-140-5p/PFN2 axis.

Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p

TUG1 Promotes Osteosarcoma Tumorigenesis by Upregulating EZH2 Expression Via Mir-144-3p.

The Role and Prognostic Value of Long Noncoding RNA TUG1 in Human Osteosarcoma:A Systematic Re-View and Meta-Analysis

LncRNA, TUG1 Regulates the Oral Squamous Cell Carcinoma Progression Possibly Via Interacting with Wnt/β-catenin Signaling.

lncRNA TUSC7 inhibits osteosarcoma progression through the miR‐181a/RASSF6 axis

LINC00174 Facilitates Cell Proliferation, Cell Migration and Tumor Growth of Osteosarcoma Via Regulating the TGF-β/SMAD Signaling Pathway and Upregulating SSH2 Expression

Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‐catenin signaling in osteosarcoma by targeting the miR‐3666/KLF7 axis

The Long Noncoding RNA TUG1 Promotes Laryngeal Cancer Proliferation and Migration.

Overexpression of Long Non-Coding Rna Tug1 Promotes Colon Cancer Progression

LncRNA TMPO‐AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR‐199a‐5p/WNT7B axis

LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis

Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.

LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis

LncRNA LINC00588 Suppresses the Progression of Osteosarcoma by Acting As a Cerna for Mirna-1972.

Long Non-coding RNA MRUL Contributes to Osteosarcoma Progression Through the Mir-125A-5p/fut4 Axis.

ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression

The Lncrna TUG1 Promotes Cell Growth and Migration in Colorectal Cancer Via the TUG1-miR-145-5p-TRPC6 Pathway

Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.